WuXi XDC Cayman Inc.

HK$70.60As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2268Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR 35.98%
Div yield —
ROE 16.33%
Diagnostics & Research
Beta (5Y) (0.78)
PE TTM 53.14
TSR TTM (5.99%)
Mkt cap HK$89.41B
ROIC 25.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$80
12.73%
34.60%
Hold 12|10|8|5|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.73
0.72
0.76
0.73
0.53%
4.26%
1.28%
(2.97%)
Revenue¥B
10.48
10.80
10.78
10.71
7.30%
5.22%
6.99%
6.19%
Peers (US$11.40B)
Cap (US$)
PE
980.7M
118.3x
12.33B
23.92x
Capital
TTM
5Y
10Y
Leveragex
3.166
(0.299)
(0.293)
EBIT/Intx
0.473
0.635
0.597
Own earn%
(47.61)
(223.77)
(183.21)
Sh yield%
34.01
14.21
15.45
Owners
Insiders/Inst%
8.28
71.36
Short interest%
4.60
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
14–20
$1 testx
0.5
Incr. ROIC%
37